462 related articles for article (PubMed ID: 8982745)
21. Progesterone receptor in Norplant endometrium.
Lau TM; Witjaksono J; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():90-4. PubMed ID: 8982750
[TBL] [Abstract][Full Text] [Related]
22. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
[TBL] [Abstract][Full Text] [Related]
23. The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use.
Kaewrudee S; Taneepanichskul S; Jaisamraun U; Reinprayoon D
Contraception; 1999 Jul; 60(1):25-30. PubMed ID: 10549449
[TBL] [Abstract][Full Text] [Related]
24. Perivascular smooth muscle alpha-actin is reduced in the endometrium of women with progestin-only contraceptive breakthrough bleeding.
Rogers PA; Plunkett D; Affandi B
Hum Reprod; 2000 Aug; 15 Suppl 3():78-84. PubMed ID: 11041224
[TBL] [Abstract][Full Text] [Related]
25. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
[TBL] [Abstract][Full Text] [Related]
26. The measurement of endometrial perfusion in norplant users: a pilot study.
Hickey M; Carati C; Manconi F; Gannon BJ; Dwarte D; Fraser IS
Hum Reprod; 2000 May; 15(5):1086-91. PubMed ID: 10783358
[TBL] [Abstract][Full Text] [Related]
27. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
[TBL] [Abstract][Full Text] [Related]
28. Management of irregular uterine bleeding and spotting associated with Norplant.
Archer DF; Philput CA; Weber ME
Hum Reprod; 1996 Oct; 11 Suppl 2():24-30. PubMed ID: 8982742
[TBL] [Abstract][Full Text] [Related]
29. Precise measurements of intrauterine vascular structures at hysteroscopy in menorrhagia and during Norplant use.
Hickey M; Dwarte D; Fraser IS
Hum Reprod; 1998 Nov; 13(11):3190-6. PubMed ID: 9853879
[TBL] [Abstract][Full Text] [Related]
30. Menstrual bleeding patterns in Norplant-2 implant users.
Biswas A; Leong WP; Ratnam SS; Viegas OA
Contraception; 1996 Aug; 54(2):91-5. PubMed ID: 8842585
[TBL] [Abstract][Full Text] [Related]
31. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
32. Bcl-2, Fas and caspase 3 expression in endometrium from levonorgestrel implant users with and without breakthrough bleeding.
Rogers PA; Lederman F; Plunkett D; Affandi B
Hum Reprod; 2000 Aug; 15 Suppl 3():152-61. PubMed ID: 11041231
[TBL] [Abstract][Full Text] [Related]
33. A 2-year comparative study of endometrial histology and cervical cytology of contraceptive implant users in Birmingham, UK.
Mascarenhas L; van Beek A; Bennink HC; Newton J
Hum Reprod; 1998 Nov; 13(11):3057-60. PubMed ID: 9853856
[TBL] [Abstract][Full Text] [Related]
34. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
35. Angiogenic effects of norplant contraception on endometrial histology and uterine bleeding.
Pritts EA; Ryan IP; Mueller MD; Lebovic DI; Shifren JL; Zaloudek CJ; Korn AP; Darney PD; Taylor RN
J Clin Endocrinol Metab; 2005 Apr; 90(4):2142-7. PubMed ID: 15623808
[TBL] [Abstract][Full Text] [Related]
36. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
37. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
Shaaban MM; Segal S; Salem HT; Ghaneimah SA; Khalifa EA; Ahmed AG
Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
[TBL] [Abstract][Full Text] [Related]
38. Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding.
Hickey M; Dwarte D; Fraser IS
Hum Reprod; 2000 Jul; 15(7):1509-14. PubMed ID: 10875858
[TBL] [Abstract][Full Text] [Related]
39. Endometrial effects of levonorgestrel and estradiol: A Scanning electron microscopic study of the luminal epithelium.
Nilsson O; Englund D; Weiner E; Victor A
Contraception; 1980 Jul; 22(1):71-83. PubMed ID: 6774851
[TBL] [Abstract][Full Text] [Related]
40. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
